Home

rovnice rozmazlovat dva cholangiocarcinoma keratin marker Lokomotiva klíč Plenární schůze

IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors  in Hepatobiliary Carcinogenesis
IJMS | Free Full-Text | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis

Diagnostic and prognostic impact of cytokeratin 18 expression in human  tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine |  Full Text
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text

Pathologic differential diagnosis of metastatic carcinoma in the liver
Pathologic differential diagnosis of metastatic carcinoma in the liver

Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and  prognosis - ScienceDirect
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis - ScienceDirect

Diagnostic and prognostic impact of cytokeratin 18 expression in human  tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine |  Full Text
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors | Molecular Medicine | Full Text

Expression of Molecular Differentiation Markers Does Not Correlate with  Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma |  PLOS ONE
Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma | PLOS ONE

Morphological subclassification of intrahepatic cholangiocarcinoma:  etiological, clinicopathological, and molecular features | Modern Pathology
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology

The expression of arginase-1, keratin (K) 8 and K18 in combined  hepatocellular-cholangiocarcinoma, subtypes with stem-cell features,  intermediate-cell type | Journal of Clinical Pathology
The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type | Journal of Clinical Pathology

Cholangiocarcinoma | Nature Reviews Gastroenterology & Hepatology
Cholangiocarcinoma | Nature Reviews Gastroenterology & Hepatology

Representative scores of keratin 7 (K7) immunoexpression in cholestatic...  | Download Scientific Diagram
Representative scores of keratin 7 (K7) immunoexpression in cholestatic... | Download Scientific Diagram

How do I distinguish cholangiocarcinoma from metastatic carcinoma and why  does it matter? - ScienceDirect
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect

Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update
Cancers | Free Full-Text | Pathology of Combined Hepatocellular Carcinoma- Cholangiocarcinoma: An Update

Cancers | Free Full-Text | Extrahepatic Distal Cholangiocarcinoma vs.  Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for  Differential Diagnosis and Treatment
Cancers | Free Full-Text | Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment

Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular  Carcinoma and Cholangiocarcinoma—What Do We Already Know
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know

Cholangiocarcinoma display features of a neuroendocrine tumor.... |  Download Scientific Diagram
Cholangiocarcinoma display features of a neuroendocrine tumor.... | Download Scientific Diagram

Metformin exerts anti-cancerogenic effects and reverses  epithelial-to-mesenchymal transition trait in primary human intrahepatic  cholangiocarcinoma cells | Scientific Reports
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells | Scientific Reports

Cholangiocarcinoma: current knowledge and future perspectives consensus  statement from the European Network for the Study of Cholangiocarcinoma  (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology & Hepatology

Clinical relevance of biomarkers in cholangiocarcinoma: critical revision  and future directions | Gut
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut

Bile and urine peptide marker profiles: access keys to molecular pathways  and biological processes in cholangiocarcinoma | Journal of Biomedical  Science | Full Text
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma | Journal of Biomedical Science | Full Text

Frontiers | Characterization of the Estrogen Response Helps to Predict  Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
Frontiers | Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma

Cholangiocarcinoma 2020: the next horizon in mechanisms and management |  Nature Reviews Gastroenterology & Hepatology
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology

Clinical relevance of biomarkers in cholangiocarcinoma: critical revision  and future directions | Gut
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut

Morphological subclassification of intrahepatic cholangiocarcinoma:  etiological, clinicopathological, and molecular features | Modern Pathology
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features | Modern Pathology

The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type  Intrahepatic Cholangiocarcinoma | Modern Pathology
The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type Intrahepatic Cholangiocarcinoma | Modern Pathology